Karyopharm Therapeutics Inc
Karyopharm Therapeutics Inc. is a commercial-stage pharmaceutical company focused on pioneering novel cancer therapies, particularly through the use of Selective Inhibitor of Nuclear Export (SINE) technology.
The top three firms on F4's Biotech & Life Sciences investor list.